Definium Therapeutics Us, Inc.
Clinical trials sponsored by Definium Therapeutics Us, Inc., explained in plain language.
-
Microdosing LSD shows promise for ADHD control in groundbreaking trial
Disease control CompletedThis study tested whether repeated low doses of LSD (about 20% of a typical recreational dose) could safely help control ADHD symptoms in adults. Fifty-three adults with ADHD received either the LSD treatment or a placebo twice weekly for six weeks in a blinded study. Researchers…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Could LSD be a new treatment for severe anxiety?
Symptom relief CompletedThis study tested whether a drug based on LSD (called MM120) could help reduce symptoms of generalized anxiety disorder. About 200 adults with significant anxiety received one of four different doses or a placebo (inactive substance) to see which worked best. Researchers measured…
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Mar 17, 2026 12:55 UTC